Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas. [electronic resource]
Producer: 19900222Description: 94-102 p. digitalISSN:- 0732-183X
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bleomycin -- administration & dosage
- Bone Marrow Transplantation
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Follow-Up Studies
- HIV Seropositivity -- epidemiology
- Humans
- Leucovorin -- administration & dosage
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasm Staging
- Prednisone -- administration & dosage
- Prognosis
- Randomized Controlled Trials as Topic
- Remission Induction
- Time Factors
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.